Can online tools boost genetic testing in families with hereditary cancer?
NCT ID NCT06927947
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether web-based tools can help people with hereditary cancer syndromes share risk information with their relatives and encourage them to get genetic testing. Researchers will enroll 625 participants (patients and their relatives) and track how many use the tools and how many relatives follow through with testing. The goal is to improve the low rate (20-30%) of genetic testing among at-risk family members.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Web-based tools (invitation tool, virtual genetics navigator, genetic testing family letter)
What this could lead to
If successful, this could improve how families communicate about hereditary cancer risk and increase the number of at-risk relatives who get tested.
What could go wrong
This is an early-stage study focused on feasibility and uptake, not on health outcomes. The tools may not significantly change behavior, and results may not apply to all populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan Comprehensive Cancer Center
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••